preladenant
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for preladenant, covering 2016-02-11 to 2019-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062) [Phase 1]